Intravenous Self-Administration of Metallic Mercury: Report of a Cas with a 5-year Follow-Up
Authors:
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 35 (1) , 83-87
Abstract
Case Report: A case of intravenous self-administration of elementary mercury is presented. The increase urinary excretion of mercury after treatment with 2,3-dimercaptopropane-1-sulfonate is reported on a 5-year follow-up. No biochemical abnormalities in hepatic or renal function nor clinical function nor clinical pulmonary malfunction have been detected, despite the persistence of metallic densities in the body. The only persistent symptoms are tremor and lower extremity weakness. Any long term benefits of 2,3-dimercaptopropane-1-sulfonate treatment remains to be determinedKeywords
This publication has 6 references indexed in Scilit:
- Evaluation of Urinary Mercury Excretion After Administration of 2,3-Dimercapto-1-propane Sulfonic Acid to Occupationally Exposed MenJournal of Toxicology: Clinical Toxicology, 1995
- Human Studies with the Chelating Agents, DMPS and DMSAJournal of Toxicology: Clinical Toxicology, 1992
- Repeated Suicide Attempts by the Intravenous Injection of Elemental MercuryThe International Journal of Psychiatry in Medicine, 1989
- Intravenous Self-Administration of Metallic Mercury in Attempted SuicideChest, 1978
- Metallic Mercury EmbolismJAMA, 1965
- Metallic Mercury Embolization—Clinical and ExperimentalArchives of internal medicine (1960), 1957